Post-approval studies (Phase 4)Study completedNCT00389025What this trial is testingMast-Cell Stabilizing Effects of OlopatadineWho this might be right forAllergic Conjunctivitis Alcon Research 24
Post-approval studies (Phase 4)Study completedNCT02251613What this trial is testingEffectiveness of Olopatadine HCl Ophthalmic Solution for the Treatment of Allergic Conjunctivitis in JapanWho this might be right forAllergic Conjunctivitis Alcon Research 50
Not applicableStudy completedNCT02503956What this trial is testingPerforated Punctal Plugs for Treatment of Papillary Conjunctivitis in Otherwise Healthy PatientsWho this might be right forEpiphoraConjunctivitis Rabin Medical Center 14
Large-scale testing (Phase 3)Study completedNCT01881113What this trial is testingA Multi-Center, Evaluation of the Onset and Duration of Action of AC-170 0.24% Compared to VehicleWho this might be right forAllergic Conjunctivitis Aciex Therapeutics, Inc. 101
Large-scale testing (Phase 3)Study completedNCT02988882What this trial is testingOTX-15-002: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic ConjunctivitisWho this might be right forChronic Allergic Conjunctivitis Ocular Therapeutix, Inc. 86
Post-approval studies (Phase 4)WithdrawnNCT00489398What this trial is testingComparison of CL Wear Between Two Allergy DropsWho this might be right forAllergic Conjunctivitis Hom, Milton M., OD, FAAO 25
Post-approval studies (Phase 4)Study completedNCT02308501What this trial is testingA Single-Center Evaluation of the Anti-Inflammatory Effects of Lastacaft as Measured by In-Vivo Confocal MicroscopyWho this might be right forAllergic Conjunctivitis ORA, Inc. 25
Post-approval studies (Phase 4)UnknownNCT03186755What this trial is testingClinical Evaluation of Hylo-Dual Versus Patanol in Children With Seasonal Allergic ConjunctivitisWho this might be right forConjunctivitis, AllergicConjunctivitis, Vernal Michael Marchand, MD 42
Testing effectiveness (Phase 2)UnknownNCT01878929What this trial is testingThe Effect of Pollen Season on Subcutaneous Allergen Immunotherapy ReactionsWho this might be right forAllergic RhinitisAsthmaAllergic Conjunctivitis University Hospitals Cleveland Medical Center 245
Large-scale testing (Phase 3)Study completedNCT01551056What this trial is testingA Multi-Center Study Evaluating the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle in the Conjunctival Allergen Challenge (CAC)Who this might be right forAllergic Conjunctivitis Aciex Therapeutics, Inc. 91
Not applicableStudy completedNCT01471184What this trial is testingThe Effects of Ectoin® Allergy Nasal Spray and Ectoin® Allergy Eye Drops Compared to PlaceboWho this might be right forAllergic RhinitisAllergic Conjunctivitis Bitop AG 46
Testing effectiveness (Phase 2)Study completedNCT03709121What this trial is testingA Methodology Development Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjunctivitis Using the Environmental Exposure ChamberWho this might be right forConjunctivitis, Allergic Aldeyra Therapeutics, Inc. 70
Post-approval studies (Phase 4)Study completedNCT00655109What this trial is testingA Comparison of Olopatadine and Fluticasone in Patients With Allergic ConjunctivitisWho this might be right forConjunctivitis, Allergic Greiner, Jack V., OD DO PhD 60
Not applicableStudy completedNCT00987467What this trial is testingLong-term Topical Cyclosporine for Atopic KeratoconjunctivitisWho this might be right forAtopic Keratoconjunctivitis Johns Hopkins University 12
Not applicableStudy completedNCT00982163What this trial is testingA Single-Center Evaluation of the Pattern of Allergic Signs and Symptoms During 4 Weeks in Ragweed SeasonWho this might be right forAllergic Conjunctivitis ORA, Inc. 34
Testing effectiveness (Phase 2)UnknownNCT06153342What this trial is testingTL-925 for the Treatment of Allergic ConjunctivitisWho this might be right forAllergic Conjunctivitis Telios Pharma, Inc. 70
Testing effectiveness (Phase 2)Study completedNCT06293820What this trial is testingTL-925 For The Treatment of ACWho this might be right forAllergic Conjunctivitis Telios Pharma, Inc. 80
Large-scale testing (Phase 3)Study completedNCT04050865What this trial is testingA Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Allergic ConjunctivitisWho this might be right forAllergic Conjunctivitis Ocular Therapeutix, Inc. 96
Post-approval studies (Phase 4)Study completedNCT01569191What this trial is testingNon-Pharmaceutical Treatment of Seasonal Allergic ConjunctivitisWho this might be right forHypersensitivity Aston University 18
Large-scale testing (Phase 3)Study completedNCT00889330What this trial is testingSafety and Efficacy Study of a Eye Drop for Eye AllergyWho this might be right forAllergic Conjunctivitis Vistakon Pharmaceuticals 60